Condition Guide

Ruxolitinib cream for eczema: a non-steroid option, who it suits and what to expect

Reviewed by Dr [PLACEHOLDER], dermatologist · Last reviewed [PLACEHOLDER date]

Ruxolitinib cream (sold as Opzelura in the US) is a steroid-free JAK-inhibitor cream for mild to moderate atopic dermatitis. Rutinib is a Bangladeshi generic with the same active ingredient and strength.

Animation to be produced (60–90 seconds): immune T cells attack pigment cells, the interferon-gamma signal passes through JAK1 and JAK2, ruxolitinib blocks it where the cream is applied, and colour can slowly return. A full transcript will sit under the video. Background: Servier Medical Art, CC BY 4.0

Who it is for

• Mild to moderate atopic dermatitis
• Age 2 or older
• Not immunocompromised
• Other prescription creams have not controlled it well enough, or are not advisable
• Treated area up to 20% of body surface

How to use it

1. Apply a thin layer twice a day to affected skin.
2. Do not cover treated skin with dressings.
3. For short-term and non-continuous use as directed by your doctor.

What to expect

Itch [PLACEHOLDER: trial data on itch relief with source]

Review at 8 weeks If there is no improvement within 8 weeks, see your doctor again (from the label).

Compared with steroid creams

Parameter / Feature	Steroid creams	Ruxolitinib cream
How it works	Reduce inflammation broadly	Blocks JAK signalling in the skin
Skin thinning with long use	[PLACEHOLDER]	[PLACEHOLDER]
Use on face and folds	[PLACEHOLDER]	[PLACEHOLDER]
Cost	[PLACEHOLDER]	[PLACEHOLDER]

Full comparison of eczema treatments →

For parents

Children from age 2 can use it, with a lower maximum amount. Keep a simple diary of flares and itch to show your doctor.

Read the page for parents →

Side effects and safety

Common side effects reported include [PLACEHOLDER from label].

Full safety information →

Cost per month

How much you will spend depends on the surface area treated. Use the tube calculator →

Area treated	Tubes per month	Cost per month
Small patches	[PLACEHOLDER]	[PLACEHOLDER]
Hands and face	[PLACEHOLDER]	[PLACEHOLDER]
Up to 20% of body	[PLACEHOLDER]	[PLACEHOLDER]

Questions

Can I use it with my moisturiser?

[PLACEHOLDER: Clinical direction on emollients application intervals relative to ruxolitinib application.]

Can I use it during a flare only?

[PLACEHOLDER: Guidance regarding acute flare treatment versus short-term non-continuous maintenance.]

Can I use it on my eyelids?

[PLACEHOLDER: Safety information and warnings concerning periocular application and mucosal contact.]

Is it safe while breastfeeding?

[PLACEHOLDER: Pharmacokinetic excretion data and recommendations for lactating mothers.]

Is ruxolitinib cream a steroid?

No. Ruxolitinib is a JAK inhibitor, not a corticosteroid, so it does not cause steroid-type skin thinning. It has its own warnings, including the boxed warning for the JAK-inhibitor class.

How long does ruxolitinib cream take to work for eczema?

Itch can ease within days for some people. The original product’s label says that if signs and symptoms do not improve within 8 weeks, a doctor should re-evaluate treatment.

Is ruxolitinib cream approved for eczema in every country?

No. The original product is approved for atopic dermatitis in the US. In some countries, including the UK, its licence covers vitiligo only, so eczema use there is off-label [PLACEHOLDER: confirm current approvals by country].

Sources

1. Opzelura prescribing information, revised 06/2026.
2. [PLACEHOLDER: dermatology guideline source].